Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,142 | 426 | 99.5% |
| Education | $33.70 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,233 | 84 | $0 (2022) |
| Novo Nordisk Inc | $579.67 | 45 | $0 (2022) |
| GlaxoSmithKline, LLC. | $500.33 | 40 | $0 (2022) |
| ABBVIE INC. | $487.93 | 29 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $386.09 | 23 | $0 (2022) |
| Allergan, Inc. | $353.94 | 21 | $0 (2020) |
| Amgen Inc. | $335.90 | 21 | $0 (2022) |
| Merck Sharp & Dohme LLC | $280.71 | 20 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $244.33 | 16 | $0 (2022) |
| Lilly USA, LLC | $216.54 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.92 | 2 | Exact Sciences Corporation ($33.92) |
| 2022 | $567.91 | 34 | AstraZeneca Pharmaceuticals LP ($155.22) |
| 2021 | $1,302 | 82 | AbbVie Inc. ($230.52) |
| 2020 | $706.60 | 45 | AstraZeneca Pharmaceuticals LP ($181.11) |
| 2019 | $1,155 | 94 | PFIZER INC. ($157.82) |
| 2018 | $1,202 | 81 | AstraZeneca Pharmaceuticals LP ($262.12) |
| 2017 | $1,208 | 92 | AstraZeneca Pharmaceuticals LP ($325.22) |
All Payment Transactions
430 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Oncology | ||||||
| 05/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Oncology | ||||||
| 08/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardio-renal | ||||||
| 07/14/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DIABETES | ||||||
| 05/26/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes | ||||||
| 05/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: DIABETES | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/28/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 04/14/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Inflammation | ||||||
| 04/12/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/07/2022 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $13.97 | General |
| 04/05/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: DIABETES | ||||||
| 03/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 02/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,473 | 2,028 | $257,689 | $95,096 |
| 2022 | 20 | 940 | 1,515 | $224,233 | $102,669 |
| 2021 | 23 | 1,333 | 2,669 | $290,439 | $159,512 |
| 2020 | 23 | 1,687 | 3,079 | $333,800 | $159,832 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 397 | $115,924 | $32,808 | 28.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 68 | 68 | $30,600 | $18,837 | 61.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 149 | 149 | $44,402 | $18,335 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 96 | $19,776 | $6,156 | 31.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $6,768 | $2,713 | 40.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 143 | 205 | $8,200 | $2,672 | 32.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 154 | 227 | $7,037 | $2,333 | 33.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $4,026 | $2,295 | 57.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 68 | 68 | $3,400 | $2,027 | 59.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 162 | 243 | $3,889 | $1,986 | 51.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 84 | 118 | $2,950 | $1,123 | 38.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 48 | 63 | $3,150 | $1,024 | 32.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $1,600 | $953.92 | 59.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 77 | 99 | $1,980 | $747.62 | 37.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 33 | $1,056 | $315.53 | 29.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 27 | 31 | $372.00 | $175.46 | 47.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 27 | 31 | $341.00 | $157.48 | 46.2% |
| 83550 | Iron binding capacity | Office | 2023 | 13 | 16 | $624.00 | $137.12 | 22.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $442.00 | $122.21 | 27.6% |
| 83540 | Iron level | Office | 2023 | 13 | 16 | $400.00 | $101.44 | 25.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 56 | $672.00 | $41.86 | 6.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 16 | $80.00 | $35.20 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 421 | 894 | $140,158 | $67,333 | 48.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 62 | 62 | $16,228 | $7,928 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 129 | $16,564 | $6,692 | 40.4% |
About Dr. Jared Dayton, DO
Dr. Jared Dayton, DO is a Family Medicine healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508816331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jared Dayton, DO has received a total of $6,176 in payments from pharmaceutical and medical device companies, with $33.92 received in 2024. These payments were reported across 430 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($6,142).
As a Medicare-enrolled provider, Dayton has provided services to 5,433 Medicare beneficiaries, totaling 9,291 services with total Medicare billing of $517,109. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mesa, AZ
- Active Since 05/11/2006
- Last Updated 09/10/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508816331
Products in Payments
- FARXIGA (Drug) $955.66
- TRELEGY ELLIPTA (Drug) $313.61
- JARDIANCE (Drug) $296.01
- UBRELVY (Drug) $240.11
- Victoza (Drug) $225.29
- CHANTIX (Drug) $195.10
- JANUVIA (Drug) $188.22
- Ozempic (Drug) $129.91
- Synthroid (Drug) $129.41
- NURTEC ODT (Drug) $128.38
- Trintellix (Drug) $121.38
- LINZESS (Drug) $118.63
- TRINTELLIX (Drug) $114.85
- BYDUREON (Drug) $114.56
- EVENITY (Biological) $113.79
- Prolia (Biological) $110.04
- XARELTO (Drug) $109.52
- BYSTOLIC (Drug) $109.04
- Tresiba (Drug) $98.51
- TRULICITY (Drug) $95.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mesa
Terry O'reilly, M.d, M.D
Family Medicine — Payments: $586,349
Suzanne Bentz, Do, DO
Family Medicine — Payments: $165,113
Cory Anderson, Md, MD
Family Medicine — Payments: $152,799
Donna Desantis, Md, MD
Family Medicine — Payments: $76,940
Yadwinder Dhillon, M.d, M.D
Family Medicine — Payments: $51,311
Dr. Karen Acevedo-Mogharbel, D.o, D.O
Family Medicine — Payments: $46,281